Efficient generation of functional pancreatic β‐cells from human induced pluripotent stem cells

  • Shigeharu G. Yabe
    Department of Regenerative Medicine, Research Institute National Center for Global Health and Medicine Tokyo Japan
  • Satsuki Fukuda
    Department of Regenerative Medicine, Research Institute National Center for Global Health and Medicine Tokyo Japan
  • Fujie Takeda
    Department of Regenerative Medicine, Research Institute National Center for Global Health and Medicine Tokyo Japan
  • Kiyoko Nashiro
    Department of Regenerative Medicine, Research Institute National Center for Global Health and Medicine Tokyo Japan
  • Masayuki Shimoda
    Pancreatic Islet Transplantation Project, Department of Diabetes Research Center National Center for Global Health and Medicine Tokyo Japan
  • Hitoshi Okochi
    Department of Regenerative Medicine, Research Institute National Center for Global Health and Medicine Tokyo Japan

Bibliographic Information

Other Title
  • 人类诱导性多能干细胞可有效生成有功能的胰腺β细胞

Description

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Insulin‐secreting cells have been generated from human embryonic or induced pluripotent stem cells (iPSCs) by mimicking developmental processes. However, these cells do not always secrete glucose‐responsive insulin, one of the most important characteristics of pancreatic β‐cells. We focused on the importance of endodermal differentiation from human iPSCs in order to obtain functional pancreatic β‐cells.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A six‐stage protocol was established for the differentiation of human iPSCs to pancreatic β‐cells using defined culture media without feeders or serum. The effects of CHIR99021, a selective glycogen synthase kinase‐3β inhibitor, were examined in the presence of fibroblast growth factor 2, activin, and bone morphogenetic protein 4 (FAB) during definitive endodermal induction by immunostaining for SRY (sex determining region Y)‐box 17 (SOX17) and Forkhead box protein A2 (FOXA2). Insulin secretion was compared between the last stage of monolayer culture and spheroid culture conditions. Cultured cells were transplanted under kidney capsules of streptozotocin‐diabetic non‐obese diabetic–severe combined immunodeficiency mice, and blood glucose levels were measured once a week. Immunohistochemical analyses were performed 4 and 12 weeks after transplantation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Addition of CHIR99021 (3 μmol/L) in the presence of FAB for 2 days improved endodermal cell viability, maintaining the high SOX17‐positive rate. Spheroid formation after the endocrine progenitor stage showed more efficient insulin secretion than did monolayer culture. After cell transplantation, diabetic mice had lower blood glucose levels, and islet‐like structures were detected in vivo.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Functional pancreatic β‐cells were generated from human iPSCs. Induction of definitive endoderm and spheroid formation may be key steps for producing these cells.</jats:p></jats:sec>

Journal

Citations (5)*help

See more

References(19)*help

See more

Related Projects

See more

Report a problem

Back to top